Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWIN
2076
Baldwin Insurance Group
BWIN
$3B
| $1.78M | ﹤0.01% |
72,000
+22,300
| +45% | +$528K |
|
|
DNB
2077
DELISTED
Dun & Bradstreet
DNB
| $1.78M | ﹤0.01% |
+153,800
| New | +$1.67M |
|
2078
Compass Minerals
CMP
$1.12B
| $1.77M | ﹤0.01% |
+52,200
| New | +$1.73M |
|
2079
Transcat
TRNS
$888M
| $1.77M | ﹤0.01% |
20,800
-1,700
| -8% | -$145K |
|
2080
Hyster-Yale Materials Handling
HY
$614M
| $1.77M | ﹤0.01% |
31,700
+15,900
| +101% | +$813K |
|
2081
Skyward Specialty Insurance
SKWD
$2.44B
| $1.77M | ﹤0.01% |
+69,693
| New | +$1.61M |
|
|
GAU
2082
Galiano Gold
GAU
$547M
| $1.76M | ﹤0.01% |
2,984,577
+250,624
| +9% | +$157K |
|
|
PPLT
2083
abrdn Physical Platinum Shares ETF
PPLT
$2B
| $1.75M | ﹤0.01% |
209,580
+162,580
| +346% | +$1.54M |
|
|
WTT
2084
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.75M | ﹤0.01% |
834,244
+64,600
| +8% | +$122K |
|
|
CDTX
2085
DELISTED
Cidara Therapeutics
CDTX
| $1.75M | ﹤0.01% |
77,479
+14,640
| +23% | +$344K |
|
|
AAN
2086
DELISTED
The Aaron's Company Inc
AAN
| $1.75M | ﹤0.01% |
123,400
-163,000
| -57% | -$2.01M |
|
2087
Security National Financial
SNFCA
$242M
| $1.74M | ﹤0.01% |
239,040
-8,557
| -3% | -$54.5K |
|
2088
Texas Capital Bancshares
TCBI
$4.38B
| $1.74M | ﹤0.01% |
33,800
+19,800
| +141% | +$987K |
|
|
PNT
2089
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.73M | ﹤0.01% |
190,975
-100,725
| -35% | -$888K |
|
2090
Upbound Group
UPBD
$1.11B
| $1.73M | ﹤0.01% |
55,512
-7,200
| -11% | -$210K |
|
2091
PDF Solutions
PDFS
$2.19B
| $1.72M | ﹤0.01% |
38,200
+14,400
| +61% | +$588K |
|
2092
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $1.72M | ﹤0.01% |
30,296
-48,275
| -61% | -$2.54M |
|
|
DCBO
2093
Docebo
DCBO
$561M
| $1.71M | ﹤0.01% |
43,400
+1,400
| +3% | +$50.7K |
|
2094
Kodak
KODK
$992M
| $1.71M | ﹤0.01% |
370,049
+41,949
| +13% | +$177K |
|
|
MTTR
2095
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.71M | ﹤0.01% |
542,700
-817,300
| -60% | -$2.27M |
|
2096
Interface
TILE
$2.23B
| $1.71M | ﹤0.01% |
194,200
+57,300
| +42% | +$439K |
|
2097
Precigen
PGEN
$2.32B
| $1.71M | ﹤0.01% |
1,483,590
-707,200
| -32% | -$835K |
|
|
DOYU
2098
DouYu International Holdings
DOYU
$138M
| $1.7M | ﹤0.01% |
162,043
-7,025
| -4% | -$74.9K |
|
2099
Avita Medical
RCEL
$251M
| $1.7M | ﹤0.01% |
100,000
-112,336
| -53% | -$1.65M |
|
|
DCPH
2100
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.7M | ﹤0.01% |
120,600
-110,718
| -48% | -$1.58M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.